Regeneron
regeneron.comLocations
Amsterdam, Netherlands · Munich, Germany · Dublin, Ireland · Mississauga, ON, Canada · Sleepy Hollow, NY, USA · Halifax, NS, Canada · Tarrytown, NY, USA · Rensselaer, NY, USA · Bernards, NJ, USA · Limerick, Ireland · Uxbridge, UK · Washington, DC, USA
industry
Biotechnology
Size
5001+ employees
Stage
Other
founded in
1988
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of products targeting eye disease, cardiovascular disease, cancer, and inflammation. Marketed products include Eylea, Praluent, Dupixent, Libtayo, and Kevzara, with ongoing development collaborations involving monoclonal and bispecific antibodies, RNAi (Alnylam), and CRISPR-based gene editing (Intellia).
Something looks off?Open jobs at Regeneron
On-site & Remote
Job function
Seniority
Salary
